retatrutide triple agonist glp-1 gip glucagon receptor Is better than tirzepatide? vs dual compared Retatrutide UK Research Library |

All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher

Some researchers run MOTS-C continuously for 16 weeks without breaks

Be skeptical of any source that does not provide testing documentation

Holliday, A

Phase 3 trial data showed up to a 2.0% A1c reduction by 68 weeks, and this is often the first place real Retatrutide results appear months before the visible body composition change

According to the New England Journal of Medicine, these findings represent one of the most significant advances in obesity pharmacotherapy to date